Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Department of Immunology, The University of Texas MD Anderson Cancer Center, 7455 Fannin Street, Box 902, Houston, TX, 77030, USA.
Front Med. 2018 Aug;12(4):451-462. doi: 10.1007/s11684-018-0651-y. Epub 2018 Jul 27.
T cells efficiently respond to foreign antigens to mediate immune responses against infections but are tolerant to self-tissues. Defect in T cell activation is associated with severe immune deficiencies, whereas aberrant T cell activation contributes to the pathogenesis of diverse autoimmune and inflammatory diseases. An emerging mechanism that regulates T cell activation and tolerance is ubiquitination, a reversible process of protein modification that is counter-regulated by ubiquitinating enzymes and deubiquitinases (DUBs). DUBs are isopeptidases that cleave polyubiquitin chains and remove ubiquitin from target proteins, thereby controlling the magnitude and duration of ubiquitin signaling. It is now well recognized that DUBs are crucial regulators of T cell responses and serve as potential therapeutic targets for manipulating immune responses in the treatment of immunological disorders and cancer. This review will discuss the recent progresses regarding the functions of DUBs in T cells.
T 细胞能够高效地对外来抗原做出反应,从而介导针对感染的免疫应答,但对自身组织具有耐受性。T 细胞激活缺陷与严重的免疫缺陷有关,而异常的 T 细胞激活则导致多种自身免疫和炎症性疾病的发病机制。一种新兴的调节 T 细胞激活和耐受的机制是泛素化,这是一种蛋白质修饰的可逆过程,由泛素连接酶和去泛素化酶(DUBs)进行反向调节。DUBs 是一类能够切割多泛素链并从靶蛋白上去除泛素的异肽酶,从而控制泛素信号的幅度和持续时间。现在人们已经认识到,DUBs 是 T 细胞反应的重要调节剂,并且可以作为治疗免疫紊乱和癌症中免疫反应的潜在治疗靶点。本文将讨论 DUBs 在 T 细胞中的功能的最新进展。